These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26822361)

  • 1. Human pharmacology for addiction medicine: From evidence to clinical recommendations.
    Quednow BB; Herdener M
    Prog Brain Res; 2016; 224():227-50. PubMed ID: 26822361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacotherapy of substance dependence and withdrawal syndromes].
    Walter M; Wiesbeck GA
    Ther Umsch; 2009 Jun; 66(6):449-57. PubMed ID: 19496041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of dual substance abuse and dependence.
    Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
    CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medications for substance use disorders (SUD): emerging approaches.
    Butelman ER; Kreek MJ
    Expert Opin Emerg Drugs; 2017 Dec; 22(4):301-315. PubMed ID: 29057665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A; Giannuzzi R; Sollazzo F; Petrongolo L; Bernardini L; Dain S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abstinence-Conflict Model: Toward an Optimal Animal Model for Screening Medications Promoting Drug Abstinence.
    Peck JA
    Int Rev Neurobiol; 2016; 126():391-402. PubMed ID: 27055619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological treatment of substance dependence from a neuroscientific perspective (II): alcohol, benzodiazepines and nicotine].
    Haro G; Cervera G; Martinez-Raga J; Pérez-Gálvez B; Fernandez-Garcés M; Sanjuan J
    Actas Esp Psiquiatr; 2003; 31(5):284-98. PubMed ID: 14557953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of adolescent substance use disorders: a review of the literature.
    Waxmonsky JG; Wilens TE
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):810-25. PubMed ID: 16262597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs.
    Saxon AJ; McCarty D
    Pharmacol Ther; 2005 Oct; 108(1):119-28. PubMed ID: 16055196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies.
    Hart CL
    Drug Alcohol Depend; 2005 Nov; 80(2):147-59. PubMed ID: 15899556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence.
    Carfora A; Cassandro P; Feola A; La Sala F; Petrella R; Borriello R
    J Bioeth Inq; 2018 Mar; 15(1):45-55. PubMed ID: 29350320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future pharmacological treatments for substance use disorders.
    Forray A; Sofuoglu M
    Br J Clin Pharmacol; 2014 Feb; 77(2):382-400. PubMed ID: 23039267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options and challenges for substances of abuse.
    Gardner TJ; Kosten TR
    Dialogues Clin Neurosci; 2007; 9(4):431-45. PubMed ID: 18286802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research issues related to development of medications for treatment of cocaine addiction.
    Klein M
    Ann N Y Acad Sci; 1998 May; 844():75-91. PubMed ID: 9668666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in the pharmacotherapy of substance abuse.
    O'Brien CP
    J Consult Clin Psychol; 1996 Aug; 64(4):677-86. PubMed ID: 8803357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of vaccines for substance use disorders: A brief review of human studies.
    Truong TT; Kosten TR
    J Neurol Sci; 2022 Mar; 434():120098. PubMed ID: 34952345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal Models and the Development of Vaccines to Treat Substance Use Disorders.
    Ohia-Nwoko O; Kosten TA; Haile CN
    Int Rev Neurobiol; 2016; 126():263-91. PubMed ID: 27055616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication development for addictive disorders: the state of the science.
    Vocci FJ; Acri J; Elkashef A
    Am J Psychiatry; 2005 Aug; 162(8):1432-40. PubMed ID: 16055764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.